Larimar Therapeutics stock price target lowered to $7 at Jones Trading
NegativeFinancial Markets

Larimar Therapeutics has faced a setback as Jones Trading has lowered its stock price target to $7. This adjustment reflects concerns about the company's performance and market conditions, which could impact investor confidence and the company's future growth prospects.
— Curated by the World Pulse Now AI Editorial System